On Sept. 6, 2016, Pfizer’s Centers for Therapeutic Innovation (CTI) staff will begin accepting research proposals from NIH intramural scientists. Led by NCATS, the Pfizer CTI program at NIH is designed to help bridge the gap between early scientific discovery and its translation into new medicines through public-private resource sharing. The program pairs leading NIH intramural researchers with Pfizer resources to pursue scientific and medical advances through joint therapeutic development. Goals include identifying biologic compounds with activity in a pathway or target of interest to both NIH and Pfizer and then together moving the compounds into the clinic to test them.
The deadline for submitting applications to the relevant NIH Institute or Center technology transfer offices is Oct. 7, 2016. Visit the CTI Call for Proposals page for details about how to apply, key deadlines, therapeutic areas of interest and criteria for success. To set a meeting that can include non-confidential discussion about pre-proposal ideas, contact Pfizer CTI Representative Nader Halim, Ph.D., at firstname.lastname@example.org, and copy NIH-PfizerCTI@mail.nih.gov.